164 related articles for article (PubMed ID: 21803581)
1. Whole-body muscle MRI in 20 patients suffering from late onset Pompe disease: Involvement patterns.
Carlier RY; Laforet P; Wary C; Mompoint D; Laloui K; Pellegrini N; Annane D; Carlier PG; Orlikowski D
Neuromuscul Disord; 2011 Nov; 21(11):791-9. PubMed ID: 21803581
[TBL] [Abstract][Full Text] [Related]
2. Correlation between quantitative whole-body muscle magnetic resonance imaging and clinical muscle weakness in Pompe disease.
Horvath JJ; Austin SL; Case LE; Greene KB; Jones HN; Soher BJ; Kishnani PS; Bashir MR
Muscle Nerve; 2015 May; 51(5):722-30. PubMed ID: 25155446
[TBL] [Abstract][Full Text] [Related]
3. Charcot-Marie-Tooth disease type 1A duplication: spectrum of clinical and magnetic resonance imaging features in leg and foot muscles.
Gallardo E; García A; Combarros O; Berciano J
Brain; 2006 Feb; 129(Pt 2):426-37. PubMed ID: 16317020
[TBL] [Abstract][Full Text] [Related]
4. Whole-Body Muscle Magnetic Resonance Imaging in Glycogen-Storage Disease Type III.
Tobaly D; Laforêt P; Perry A; Habes D; Labrune P; Decostre V; Masingue M; Petit F; Barp A; Bello L; Carlier P; Carlier RY
Muscle Nerve; 2019 Jul; 60(1):72-79. PubMed ID: 30972778
[TBL] [Abstract][Full Text] [Related]
5. Late-onset Pompe disease (LOPD): correlations between respiratory muscles CT and MRI features and pulmonary function.
Gaeta M; Barca E; Ruggeri P; Minutoli F; Rodolico C; Mazziotti S; Milardi D; Musumeci O; Toscano A
Mol Genet Metab; 2013 Nov; 110(3):290-6. PubMed ID: 23916420
[TBL] [Abstract][Full Text] [Related]
6. MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.
Farrugia ME; Robson MD; Clover L; Anslow P; Newsom-Davis J; Kennett R; Hilton-Jones D; Matthews PM; Vincent A
Brain; 2006 Jun; 129(Pt 6):1481-92. PubMed ID: 16672291
[TBL] [Abstract][Full Text] [Related]
7. Whole body muscle MRI protocol: pattern recognition in early onset NM disorders.
Quijano-Roy S; Avila-Smirnow D; Carlier RY;
Neuromuscul Disord; 2012 Oct; 22 Suppl 2():S68-84. PubMed ID: 22980770
[TBL] [Abstract][Full Text] [Related]
8. [A retrospective study of six patients with late-onset Pompe disease].
Saux A; Laforet P; Pagès AM; Figarella-Branger D; Pellissier JF; Pagès M; Labauge P
Rev Neurol (Paris); 2008 Apr; 164(4):336-42. PubMed ID: 18439925
[TBL] [Abstract][Full Text] [Related]
9. Muscle MRI Findings in Childhood/Adult Onset Pompe Disease Correlate with Muscle Function.
Figueroa-Bonaparte S; Segovia S; Llauger J; Belmonte I; Pedrosa I; Alejaldre A; Mayos M; Suárez-Cuartín G; Gallardo E; Illa I; Díaz-Manera J;
PLoS One; 2016; 11(10):e0163493. PubMed ID: 27711114
[TBL] [Abstract][Full Text] [Related]
10. Whole-body magnetic resonance imaging in late-onset Pompe disease: Clinical utility and correlation with functional measures.
Khan AA; Boggs T; Bowling M; Austin S; Stefanescu M; Case L; Kishnani PS
J Inherit Metab Dis; 2020 May; 43(3):549-557. PubMed ID: 31710733
[TBL] [Abstract][Full Text] [Related]
11. Pattern of skeletal muscle involvement in primary dysferlinopathies: a whole-body 3.0-T magnetic resonance imaging study.
Kesper K; Kornblum C; Reimann J; Lutterbey G; Schröder R; Wattjes MP
Acta Neurol Scand; 2009 Aug; 120(2):111-8. PubMed ID: 19154541
[TBL] [Abstract][Full Text] [Related]
12. 24-months results in two adults with Pompe disease on enzyme replacement therapy.
Vielhaber S; Brejova A; Debska-Vielhaber G; Kaufmann J; Feistner H; Schoenfeld MA; Awiszus F
Clin Neurol Neurosurg; 2011 Jun; 113(5):350-7. PubMed ID: 21477922
[TBL] [Abstract][Full Text] [Related]
13. Acute progression of neuromuscular findings in infantile Pompe disease.
Burrow TA; Bailey LA; Kinnett DG; Hopkin RJ
Pediatr Neurol; 2010 Jun; 42(6):455-8. PubMed ID: 20472203
[TBL] [Abstract][Full Text] [Related]
14. Trunk muscle involvement in late-onset Pompe disease: study of thirty patients.
Alejaldre A; Díaz-Manera J; Ravaglia S; Tibaldi EC; D'Amore F; Morís G; Muelas N; Vílchez JJ; García-Medina A; Usón M; Martínez García FA; Illa I; Pichiecchio A
Neuromuscul Disord; 2012 Oct; 22 Suppl 2():S148-54. PubMed ID: 22980766
[TBL] [Abstract][Full Text] [Related]
15. Enzyme replacement therapy in adult-onset glycogenosis II: is quantitative muscle MRI helpful?
Pichiecchio A; Poloni GU; Ravaglia S; Ponzio M; Germani G; Maranzana D; Costa A; Repetto A; Tavazzi E; Danesino C; Moglia A; Bastianello S
Muscle Nerve; 2009 Jul; 40(1):122-5. PubMed ID: 19533640
[TBL] [Abstract][Full Text] [Related]
16. Muscle MRI findings in siblings with juvenile-onset acid maltase deficiency (Pompe disease).
Dlamini N; Jan W; Norwood F; Sheehan J; Spahr R; Al-Sarraj S; Anthony Hulse J; Hughes D; Champion MP; Jungbluth H
Neuromuscul Disord; 2008 May; 18(5):408-9. PubMed ID: 18434155
[No Abstract] [Full Text] [Related]
17. Clinical features of late-onset Pompe disease: a prospective cohort study.
Wokke JH; Escolar DM; Pestronk A; Jaffe KM; Carter GT; van den Berg LH; Florence JM; Mayhew J; Skrinar A; Corzo D; Laforet P
Muscle Nerve; 2008 Oct; 38(4):1236-45. PubMed ID: 18816591
[TBL] [Abstract][Full Text] [Related]
18. Muscle MRI of classic infantile pompe patients: Fatty substitution and edema-like changes.
Pichiecchio A; Rossi M; Cinnante C; Colafati GS; De Icco R; Parini R; Menni F; Furlan F; Burlina A; Sacchini M; Donati MA; Fecarotta S; Casa RD; Deodato F; Taurisano R; Di Rocco M
Muscle Nerve; 2017 Jun; 55(6):841-848. PubMed ID: 27668838
[TBL] [Abstract][Full Text] [Related]
19. Late onset Pompe disease: clinical and neurophysiological spectrum of 38 patients including long-term follow-up in 18 patients.
Müller-Felber W; Horvath R; Gempel K; Podskarbi T; Shin Y; Pongratz D; Walter MC; Baethmann M; Schlotter-Weigel B; Lochmüller H; Schoser B
Neuromuscul Disord; 2007 Oct; 17(9-10):698-706. PubMed ID: 17643989
[TBL] [Abstract][Full Text] [Related]
20. Whole-body muscle MRI in McArdle disease.
Tobaly D; Laforêt P; Stojkovic T; Behin A; Petit FM; Barp A; Bello L; Carlier P; Carlier RY
Neuromuscul Disord; 2022 Jan; 32(1):5-14. PubMed ID: 34711478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
